TABLE 1.
Correlation between the expression of MTA1 and the clinicopathological characteristics of NPC patientsa
| Parameterb | No. of cases | MTA1 protein expression (no. of patients [%]) |
P value (chi-square test) | |
|---|---|---|---|---|
| Low expression | High expression | |||
| Sex | 0.46 | |||
| Male | 38 | 21 (55.3) | 17 (44.7) | |
| Female | 22 | 10 (45.5) | 12 (54.5) | |
| Age (yr) | 0.75 | |||
| ≤50 | 36 | 18 (50.0) | 18 (50.0) | |
| >50 | 24 | 13 (54.2) | 11 (45.8) | |
| T classification | 0.13 | |||
| T1-T2 | 33 | 20 (60.6) | 13 (39.4) | |
| T3-T4 | 27 | 11 (40.7) | 16 (59.3) | |
| N classification | <0.01 | |||
| N0-N1 | 41 | 26 (63.4) | 15 (36.6) | |
| N2-N3 | 19 | 5 (26.3) | 14 (73.7) | |
| M classification | 0.03 | |||
| M0 | 43 | 26 (60.5) | 17 (39.5) | |
| M1 | 17 | 5 (29.4) | 12 (70.6) | |
| Clinical stage | 0.06 | |||
| I-II | 26 | 17 (65.4) | 9 (34.6) | |
| III-IV | 34 | 14 (41.2) | 20 (58.8) | |
| LMP2A | 0.03 | |||
| Positive | 39 | 16 (41.0) | 23 (59.0) | |
| Negative | 21 | 15 (71.4) | 6 (28.6) | |
a
Restaged according to the 7th edition of the UICC/AJCC system (53).
b
T, primary tumor; N, regional lymph nodes; M, distant metastasis.